ABSTRACT

Almost 300,000 women die from cervical cancer each year, making it the fourth most frequent cancer in the world among women. The human papillomavirus high-risk subtypes that cause cervical cancer are the primary cause of the disease. Together with host factors, the E5, E6, and E7 viral proto-oncogene start and maintain the maligant phenotype. In low- and middle- income nations, however, the disease is fatal for women because of their limited resources, which frequently result in advanced and incurable sickness. Radiation therapy, chemotherapy, and/or surgery are available as treatments, either separately or in combination. This review outlines the causes and symptoms of cervical cancer and goes into detail about the benefits and drawbacks of the current cervical cancer therapies. The future of cervical cancer treatment is then covered, including immunotherapies, targeted medicines, combination therapies, and genetic treatment options.
Publication date: 01/03/2026

https://ijbpas.com/pdf/2026/March/MS_IJBPAS_2026_9925.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2026/15.3.9925